Climb BioCLYM

13F holders, Q2 2024 (June 30)
47holders +26
30new positions
5sold out
2famous investors
$7.11avg. 13F price*

At the end of Q2 2024, 47 institutions reported holding Climb Bio Inc. (CLYM) in their 13F filings, up 26 from Q1 2024. 30 opened new positions and 5 sold out. The largest holders were Ra Capital Management, L.P. ($223.4M), Deep Track Capital, LP ($27.8M) and Samsara Biocapital, LLC ($23.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Climb Bio Inc.
Filed as
ELIEM THERAPEUTICS INC (Q2 2024)
CUSIP
28658R106
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 21Q1 2024Q2 2024: 47Q2 2024Q3 2024: 71Q3 2024Q4 2024: 79Q4 2024Q1 2025: 75Q1 2025Q2 2025: 69Q2 2025Q3 2025: 68Q3 2025Q4 2025: 65Q4 2025Q1 2026: 80Q1 2026Q2 2026: 108Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions30$118.6M
Exits5$6.4M

All 13F filers, Q1 2024 → Q2 2024: 35,493,891 shares bought and 2,443,194 shares sold, net +33,050,697 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 47 holders

Ra Capital Management, L.P. 2.96% Add +138.9% 31,419,267 $223.4M
Deep Track Capital, LP 0.83% New 3,904,785 $27.8M
Samsara Biocapital, LLC 4.85% New 3,261,393 $23.2M
Janus Henderson Group PLC 0.01% New 3,253,988 $23.1M
Boxer Capital, LLC 0.97% New 2,603,190 $18.5M
Affinity Asset Advisors, LLC 2.06% New 1,670,661 $11.9M
Driehaus Capital Management LLC 0.05% Reduce -14.2% 696,057 $4.9M
Adage Capital Partners Gp, L.L.C. 0.01% New 670,362 $4.8M
Ally Bridge Group (NY) LLC 2.12% New 500,000 $3.6M
BlackRock Inc. 0.00% Add +1154.0% 381,723 $2.7M
Vanguard Group Inc. 0.00% Add +5.1% 326,381 $2.3M
Sphera Funds Management LTD. 0.25% New 215,179 $1.5M
Walleye Capital LLC 0.02% New 196,390 $1.4M
Geode Capital Management, LLC 0.00% Add +157.6% 171,597 $1.2M
Ikarian Capital, LLC 0.22% New 100,000 $711K
ADAR1 Capital Management, LLC 0.14% New 97,695 $695K
State Street Corp. 0.00% Add +171.9% 59,007 $420K
Bridgeway Capital Management, LLC 0.01% No change 55,223 $393K
Northern Trust Corp. 0.00% Add +5.1% 45,677 $325K
Renaissance Technologies 0.00% Add +248.5% 37,000 $263K
Man Group plc 0.00% New 33,567 $239K
Boothbay Fund Management, LLC 0.01% New 30,710 $218K
Woodline Partners LP 0.00% New 22,192 $158K
Bank of New York Mellon Corp 0.00% New 18,845 $134K
Charles Schwab Investment Management Inc. 0.00% New 17,128 $122K
New York State Common Retirement Fund 0.00% New 13,300 $95K
Dimensional Fund Advisors LP 0.00% New 12,560 $89K
Millennium Management 0.00% Reduce -43.3% 11,397 $81K
Polar Asset Management Partners Inc. 0.00% New 10,781 $77K
Two Sigma Securities, LLC 0.00% New 10,619 $76K
Morgan Stanley 0.00% Add +478.3% 9,883 $70K
Bank of America Corp. 0.00% New 9,247 $66K
Rhumbline Advisers 0.00% New 8,233 $59K
STRS Ohio 0.00% New 5,300 $38K
Corebridge Financial, Inc. 0.00% — 3,918 $28K
Wells Fargo & Company 0.00% Add +6198.0% 3,149 $22K
JPMorgan Chase & Co. 0.00% New 3,104 $22K
Osaic Holdings, Inc. 0.00% No change 8,333 $22K
Tower Research Capital LLC (TRC) 0.00% Reduce -16.3% 3,020 $21K
Barclays PLC 0.00% New 2,543 $18K
UBS Group AG 0.00% Reduce -62.6% 2,218 $16K
Citigroup Inc. 0.00% New 1,632 $12K
Ameritas Investment Partners, Inc. 0.00% New 714 $5K
Royal Bank of Canada 0.00% Add +988.9% 686 $5K
Legal & General Group Plc 0.00% New 631 $5K
California State Teachers Retirement System 0.00% New 528 $4K
Amalgamated Bank 0.00% New 252 $2K

"% of holder's portfolio" is CLYM's weight in each manager's 13F, not the share of Climb Bio Inc. the manager owns.